The 15 most recent market catalysts affecting $LIFE, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Oct 12, 2026
Corporate Catalyst
Bullish
Impact 65
Citizens Maintains Market Outperform on Ethos Technologies, Raises Price Target to $40
Citizens analyst Matthew Carletti reiterated a 'Market Outperform' rating for Ethos Technologies and raised the price target from $33 to $40. This upgrade reflects a more optimisti…
Oct 1, 2026
Corporate Catalyst
Bearish
Impact 65
JP Morgan Downgrades Ethos Technologies to Neutral, Maintains Price Target to $37
JP Morgan analyst Pablo Singzon downgraded Ethos Technologies (LIFE) from Overweight to Neutral. This change in rating signals a less optimistic view on the stock's potential for o…
Oct 1, 2026
Corporate Catalyst
Neutral
Impact 75
Watching Ethos Technologies; Hunterbrook Media Issues Report Titled, “How Ethos Sold Wall Street on AI While Powering an Analog Boiler Room”; States Hunterbrook Capital Is Short $LIFE
The 8-K filing serves as a public disclosure of a highly critical report from Hunterbrook Media concerning Ethos Technologies. The report, titled 'How Ethos Sold Wall Street on AI …
Oct 1, 2026
Corporate Catalyst
Neutral
Impact 75
Watching Ethos Technologies; The Bear Cave Newsletter Issues Report On Co Titled "More Problems at Ethos (LIFE)"
Ethos Technologies (LIFE) has filed an 8-K to announce the publication of a critical report by The Bear Cave Newsletter, titled 'More Problems at Ethos (LIFE)'. This type of report…
Aug 11, 2026
Market Technicals
Bearish
Impact 55
Top 3 Financial Stocks That Could Sink Your Portfolio In Q3
The filing identifies Ethos Technologies (LIFE), Safety Insurance Group (SAFT), and Marketaxess Holdings (MKTX) as having RSI values significantly above 70, which typically indicat…
Aug 7, 2026
Corporate Catalyst
Neutral
Impact 55
aTyr Pharma CFO Jill Broadfoot To Step Down Sept. 30, 2026
The departure of a CFO, even with a distant effective date, is a moderate corporate catalyst. While not an immediate crisis, it introduces uncertainty about aTyr Pharma's financial…
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 55
Citigroup Maintains Buy on Ethos Technologies, Raises Price Target to $33
Citigroup analyst Ronald Josey maintained a 'Buy' rating on Ethos Technologies and raised the price target from $27 to $33. This action signals continued confidence from a prominen…
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 55
Citizens Maintains Market Outperform on Ethos Technologies, Raises Price Target to $33
Citizens analyst Matthew J. Carletti has maintained a 'Market Outperform' rating on Ethos Technologies (LIFE) and raised the price target from $27 to $33. This indicates a continue…
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 95
These Analysts Boost Their Forecasts On Ethos Technologies Following Upbeat Q2 Results
Ethos Technologies (LIFE) delivered a robust Q2, surpassing analyst expectations for both earnings and revenue. The company's decision to significantly raise its FY2026 sales guida…
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 65
Baird Maintains Outperform on Ethos Technologies, Raises Price Target to $32
Baird analyst Colin Sebastian has maintained an 'Outperform' rating on Ethos Technologies (NASDAQ: LIFE) and raised the price target from $26 to $32. This analyst upgrade signals i…
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 65
Barclays Maintains Overweight on Ethos Technologies, Raises Price Target to $37
Barclays analyst Ross Sandler maintained an 'Overweight' rating on Ethos Technologies (LIFE) and significantly raised the price target from $27 to $37. This action signals increase…
Aug 3, 2026
Corporate Catalyst
Bullish
Impact 85
Ethos Technologies Raises FY2026 Sales Guidance from $561.000M-$565.000M to $727.000M-$731.000M vs $564.718M Est
Ethos Technologies (LIFE) announced a substantial increase in its FY2026 sales outlook, moving from a range of $561M-$565M to $727M-$731M. This revised guidance significantly surpa…
Aug 3, 2026
Corporate Catalyst
Bullish
Impact 95
Ethos Technologies Q2 Adj. EPS $0.53 Beats $0.26 Estimate, Sales $189.562M Beat $117.306M Estimate
Ethos Technologies reported a Q2 adjusted EPS of $0.53, significantly beating the $0.26 estimate by over 100%, and sales of $189.562 million, surpassing the $117.306 million estima…
Jul 13, 2026
Corporate Catalyst
Bullish
Impact 65
JP Morgan Maintains Overweight on Ethos Technologies, Raises Price Target to $23
JP Morgan analyst Pablo Singzon maintained an 'Overweight' rating on Ethos Technologies (LIFE) and raised the price target from $21.5 to $23. This upgrade signals increased confide…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.